Skip to main navigation Skip to search Skip to main content

Evidens og retningslinjer for influenza-og pneumokokvaccination af ældre

Translated title of the contribution: Evidence and guidelines for influenza and pneumococcal vaccines for the elderly.
    1 Citation (Scopus)

    Abstract

    Influenza and pneumococcal disease are major causes of morbidity and mortality in the elderly. In most European countries dual vaccination of persons aged > 65 years is recommended, but the evidence supporting these recommendations is limited. Inadequate immune response in elderly hampers efficacy. Immunogenicity of the influenza vaccine may be improved by adding an adjuvant. Pneumococcal vaccination of children provides herd immunity, but may also result in expansion of non-vaccine strains. Better vaccines with documentation of efficacy in the elderly are needed for both diseases.

    Translated title of the contributionEvidence and guidelines for influenza and pneumococcal vaccines for the elderly.
    Original languageDanish
    JournalUgeskrift for Laeger
    Volume175
    Issue number47
    Pages (from-to)2861-2864
    Number of pages4
    ISSN0041-5782
    Publication statusPublished - 18 Nov 2013

    Fingerprint

    Dive into the research topics of 'Evidence and guidelines for influenza and pneumococcal vaccines for the elderly.'. Together they form a unique fingerprint.

    Cite this